rs80358220
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000198.4(HSD3B2):c.664C>A(p.Pro222Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P222Q) has been classified as Pathogenic.
Frequency
Consequence
NM_000198.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSD3B2 | NM_000198.4 | c.664C>A | p.Pro222Thr | missense_variant | 4/4 | ENST00000369416.4 | NP_000189.1 | |
HSD3B2 | NM_001166120.2 | c.664C>A | p.Pro222Thr | missense_variant | 4/4 | NP_001159592.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461814Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727214
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
3 beta-Hydroxysteroid dehydrogenase deficiency Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2002 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 06, 2021 | - - |
Congenital adrenal hyperplasia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 29, 2022 | Variant summary: HSD3B2 c.664C>A (p.Pro222Thr) results in a non-conservative amino acid change located in the 3-beta hydroxysteroid dehydrogenase/isomerase domain (IPR002225) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251214 control chromosomes. c.664C>A has been reported in the literature as a homozygous genotype in at-least two individuals affected with classic salt wasting phenotype of 3-beta-hydroxysteroid dehydrogenase deficiency Congenital Adrenal Hyperplasia with subsequent citations by others (example, Pang_2002, Lutfallah_2002, Baquedano_2018, Baronio_2019, Al Alawi_2019, Guran_2020). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (example, Pang_2002). The most pronounced variant effect results in undetectable levels of normal enzyme activity in vitro using pregnenolone and dehydroepiandrosterone as substrates. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at